Therapeutic drug monitoring

Published on 01/03/2015 by admin

Filed under Basic Science

Last modified 01/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1327 times

59

Therapeutic drug monitoring

The effect of most drug therapy is assessed by observing the change in the patient’s clinical state. Therapeutic drug monitoring (TDM) is the measurement of drug concentrations in blood, plasma or saliva as a means of assessing the adequacy of dosage. TDM is not necessary where there is a clear clinical effect, such as with antihypertensive or hypoglycaemic drugs, but is important with those drugs for which there is no good objective measurement of effectiveness and/or there is a serious risk of toxicity. For TDM to be of value there must be a proven relationship between the plasma drug concentration and the clinical effect.

Following the administration of a drug, the graph of plasma concentration against time, plotted on semi-logarithmic graph paper, will look like that in Figure 59.1. Analysis of such graphs can allow an estimate of the half-life of the drug (image) and the volume of distribution, which is higher if the drug is taken up by tissues. These can be used to estimate the correct dose to give. After several similar doses have been given, the pattern reaches a steady state at which the plasma drug concentration will oscillate between a peak and a trough level. It usually takes about five half-lives for the steady state to be attained. In the steady state there is a stable relationship between the dose and the effect, and decisions can be made with confidence. For most drugs there is a linear relationship between dose and plasma concentration. However, phenytoin shows non-linear kinetics (Fig 59.2).

Interpretation of drug levels

Buy Membership for Basic Science Category to continue reading. Learn more here